https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
For PJI versus non-PJI, respectively, the following rates were recorded blood transfusions, 28.3 versus 18.4% (p $39,929), 55.8 versus 44.2% (p less then 0.0001); in-hospital mortality, 0.6 versus 0.3% (p = 0.016). In multivariable logistic regression analyses, PJI patients were more likely to receive a blood transfusion (odds ratio [OR] 1.78; p less then 0.0001), to experience postoperative complications (OR 1.56; p less then 0.0001), to have a higher in-hospital cost (OR 1.65; p less then 0.0001), to have a pLOS following surg